About this episode
Kim Branson, PhD, SVP and Global Head of AI and Machine Learning for GSK, joins Vijay Pande, founding partner at a16z Bio + Health.
Together, they talk about how AI has improved drug discovery and development, as Kim walks through all the ways AI can be deployed in the lab. They also get into detail about what an ideal partner looks like and what kind of solution is attractive to a big biopharma, making this a particularly relevant episode for builders in biotech AI.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time Raising Health publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Raising Health
Moderna CEO Stéphane Bancel on the Next Era of mRNA
Raising Health
Clinical AI Comes of Age | Suchi Saria on the Future of Healthcare
Raising Health
AI, Healthcare, and 700 Million Patients | Nicolas Abad, Telepatía
Raising Health
Healthcare Will Benefit Most from AI | Julie Yoo on StartUp Health
Raising Health